Cargando…
Considerations for routine coagulation monitoring with rivaroxaban: A case report and review of the literature
BACKGROUND: Rivaroxaban is a non-vitamin K antagonist oral anticoagulant that does not require coagulation monitoring based on current recommendations. Our goal is to explore whether routine coagulation monitoring should not be required for all patients receiving oral rivaroxaban, what relationship...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369389/ https://www.ncbi.nlm.nih.gov/pubmed/30746380 http://dx.doi.org/10.12998/wjcc.v7.i3.382 |